Dr. Reddy's Laboratories

  • Why I Like Generic Pharmaceuticals

    By Daniel Jennings - August 12, 2013 | Tickers: RDY, MYL, PRGO

    I don’t like traditional pharmaceutical houses as either a business or an investment. I think the way they try to gouge customers with no choice—sick people—with high prices is just plain wrong. The high research and development costs, sleazy marketing practices, and abuse of the patent system to needlessly jack up prices put me off.

    Yet there’s one area of the drug business I like: generic more »

  • Should These Drug Companies Continue to Pay a Dividend?

    By Chris Hodge - May 24, 2013 | Tickers: AGN, RDY, NVO

    Editor's Note: The article has been modified to better describe the current companies' dividend arrangements.

    Even a hardcore dividend addict such as I will admit that there are times when a company should hold off on paying a dividend. The following is an examination of a few companies in the drug manufacturing sector and my conclusions about their dividend arrangements. In short, should these companies continue to pay dividends more »

  • Five Stocks Recently Sold By Manning and Napier

    By Dr. Osman Gulseven - December 11, 2012 | Tickers: CL, RDY, FDX, UL, DIS

    Established in 1970 by Bill Manning and Bill Napier, Manning & Napier is on of the largest fund management companies in the U.S. For more than four decades, Manning & Napier has been leading institutional and individual clients towards their financial goals. Manning and Napier have an opportunistic investment style. The management aims to assist investors to meet a broad range of investment requirements even in the most challenging environments. As more »

  • An Interesting Emerging Market ADR

    By Shas Dey - November 21, 2012 | Tickers: RDY, GSK, PFE, TEVA

    Dr. Reddy’s Laboratories (NYSE: RDY) is an India-based integrated global pharmaceutical company. RDY is one of the largest pharmaceutical companies in India, with revenue of $2 billion in FY 2012. The company focuses on three core businesses; Pharmaceutical Services and Active Ingredients, Global Generics, and Proprietary Products.

    Pharmaceutical Services & Active Ingredients (PSAI)

    Through the PSAI unit, RDY offers speedy product development with IP advantages, as well as cost effective more »